1. Home
  2. CII vs EMBC Comparison

CII vs EMBC Comparison

Compare CII & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CII
  • EMBC
  • Stock Information
  • Founded
  • CII 2004
  • EMBC 1924
  • Country
  • CII United States
  • EMBC United States
  • Employees
  • CII N/A
  • EMBC N/A
  • Industry
  • CII Investment Bankers/Brokers/Service
  • EMBC Medical/Dental Instruments
  • Sector
  • CII Finance
  • EMBC Health Care
  • Exchange
  • CII Nasdaq
  • EMBC Nasdaq
  • Market Cap
  • CII 875.1M
  • EMBC 753.0M
  • IPO Year
  • CII N/A
  • EMBC N/A
  • Fundamental
  • Price
  • CII $20.78
  • EMBC $18.63
  • Analyst Decision
  • CII
  • EMBC Buy
  • Analyst Count
  • CII 0
  • EMBC 2
  • Target Price
  • CII N/A
  • EMBC $19.00
  • AVG Volume (30 Days)
  • CII 78.8K
  • EMBC 445.2K
  • Earning Date
  • CII 01-01-0001
  • EMBC 02-07-2025
  • Dividend Yield
  • CII 6.17%
  • EMBC 3.26%
  • EPS Growth
  • CII N/A
  • EMBC 9.84
  • EPS
  • CII N/A
  • EMBC 1.34
  • Revenue
  • CII N/A
  • EMBC $1,123,100,000.00
  • Revenue This Year
  • CII N/A
  • EMBC $0.26
  • Revenue Next Year
  • CII N/A
  • EMBC $1.24
  • P/E Ratio
  • CII N/A
  • EMBC $13.75
  • Revenue Growth
  • CII N/A
  • EMBC 0.21
  • 52 Week Low
  • CII $16.76
  • EMBC $9.93
  • 52 Week High
  • CII $19.81
  • EMBC $21.48
  • Technical
  • Relative Strength Index (RSI)
  • CII 67.07
  • EMBC 42.20
  • Support Level
  • CII $20.01
  • EMBC $19.17
  • Resistance Level
  • CII $20.46
  • EMBC $20.63
  • Average True Range (ATR)
  • CII 0.19
  • EMBC 0.86
  • MACD
  • CII 0.04
  • EMBC -0.33
  • Stochastic Oscillator
  • CII 100.00
  • EMBC 8.93

About CII Blackrock Capital and Income Fund Inc.

Blackrock Enhanced Cap&Inc Fund, Inc is a closed-end management investment company. Its objective is to provide total return through a combination of current income and capital appreciation. The trust seeks to achieve its investment objective by investing a majority of its total assets in a portfolio of equity securities of U.S. and foreign issuers.

About EMBC Embecta Corp.

Embecta Corp is a medical technology company. The company develops innovative technology, services, and solutions that help advance both clinical therapy for patients and clinical processes for healthcare providers. Its products include BD Pyxis, PureWick, Phasix among others.

Share on Social Networks: